Loading...
Loading...
- China-based healthcare products and services provider, BIMI International Medical Inc BIMI, reported Q3 sales of $13.78 million from $3.09 million a year ago.
- The Company said that the growth was mainly driven by the increase in sales of wholesale pharmaceuticals and the recently-acquired five hospitals.
- Revenues from the wholesale pharmaceuticals segment reached $8.4 million. Sales from the medical devices segment reached $1.61 million, and the services segment generated sales of $2.9 million.
- The gross profit increased to $2.03 million from $257k reported a year ago.
- BIMI reported a Q3 EPS loss of $(0.06) narrower than $(0.19) posted a year ago.
- BIMI held cash of $209k and working capital of $2.12 million.
- Price Action: BIMI shares are up 63.9% at $1.07 during the premarket session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in